Abstract:Cardiovascular disease constitutes the leading cause of mortality in patients with chronic kidney disease (CKD), which is termed cardiorenal syndrome type 4 (CRS-4). The aim of our experiments was to clarify the relationship between angiogenesis and endothelial-mesenchymal transition (End-MT) and the the development of pathological cardiac remodeling and fibrosis in unilateral urinary obstruction (UUO) rats. Also, our study was to confirm eplerenone prevents cardiac fibrosis by inhibiting angiogenesis in unilateral urinary obstruction rats. We used a 180-day rat model of unilateral ureteral obstruction (UUO) to replicate the CRS model. Using eplerenone, a blocker of mineralocorticoid receptor (MR), to test the effect of aldosterone in cardiac fibrosis induced by UUO. HE staining was performed to observe the pathology of myocardial tissue. The degree of myo-cardial tissue fibrosis was observed by Masson and Sirius red staining. Immunohistochemical staining was applied to detect the expression of CD34 and CD105 in myocardial tissue, and immunofluorescent staining was performed to examine the expression of CD34, COLI/COLIII and alpha-SMA. The expression of signal pathway-related protein VEGFA, VEGFR2, nuclear factor kappa-B and IL-1 beta were tested by western blot. RT-PCR was used to detect the mRNA levels of SGK-1, nuclear factor kappa-B and IL-1beta. The results shows that the development of pathological cardiac remodeling and cardiac dysfunction in UUO rats. Moreover, there was more angiogenesis and endothelial-mesenchymal transition (End-MT) in the UUO group, and these effects were inhibited by eplerenone. The results indicated that this cardiac fibrosis was associated with angiogenesis and endothelial-mesenchymal transition (End-MT) related to aldosterone and mineralocorticoid receptor (MR) activation. Moreover, in association with the MR/IL-1beta/VEGFA signaling pathway, early treatment with the MR antagonist eplerenone in rats with UUO-induced CKD may significantly attenuate MR activation and cardiac fibrosis.

UUO induces lung fibrosis with macrophage-myofibroblast transition in rats

Eplerenone ameliorates lung fibrosis in unilateral ureteral obstruction rats by inhibiting lymphangiogenesis

Mefunidone Attenuates Tubulointerstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction.

Eplerenone inhibits UUO-induced lymphangiogenesis and cardiac fibrosis by attenuating inflammatory injury

The Inhibitory Effect of Eplerenone on Cell Proliferation in the Contralateral Kidneys of Rats with Unilateral Ureteral Obstruction.

PS-B03-9: EPLERENONE PREVENTS CARDIAC FIBROSIS BY INHIBITING ANGIOGENESIS IN UNILATERAL URINARY OBSTRUCTION RATS

The role of murine M1 macrophages from different sources in unilateral ureteral obstruction

Mitophagy Induced by UMI-77 Preserves Mitochondrial Fitness in Renal Tubular Epithelial Cells and Alleviates Renal Fibrosis

Signaling Mechanism of Renal Fibrosis in Unilateral Ureteral Obstructive Kidney Disease in Rock1 Knockout Mice

Eplerenone reduces lymphangiogenesis in the contralateral kidneys of UUO rats

Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction

Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments

Renoprotection of Microcystin-RR in Unilateral Ureteral Obstruction-Induced Renal Fibrosis: Targeting the PKM2-HIF-1α Pathway

PS 04-30 THE EFFECT OF EPLERENONE ON CELL PROLIFERATION IN CONTRALATERAL KIDNEY OF RATS WITH UNILATERAL URETERAL OBSTRUCTION

Eplerenone Ameliorates Cell Pyroptosis in Contralateral Kidneys of Rats with Unilateral Ureteral Obstruction.

Verbascoside Alleviates Renal Fibrosis in Unilateral Ureteral Obstruction Rats by Inhibiting Macrophage Infiltration

Effect of Mycophenolate Mofetil(MMF) on the Expression of P-Smad2/3 in Unilateral Ureteral Obstruction(UUO) Rats

Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction

MK-2206 Alleviates Renal Fibrosis by Suppressing the Akt/mTOR Signaling Pathway In Vivo and In Vitro

Protective Effects of GPR120 Agonist-Programmed Macrophages on Renal Interstitial Fibrosis in Unilateral Ureteral Obstruction (UUO) Rats

Longitudinal analysis of fecal microbiome and metabolome during renal fibrotic progression in a unilateral ureteral obstruction animal model